BioCentury | Nov 10, 2014
Company News

Doliage, Nicox deal

...Nicox acquired French ophthalmic play Doliage for EUR5 million ($6.2 million) in newly issued Nicox shares...
...of its strategy to develop an ophthalmic commercial infrastructure in the five major European markets. Doliage...
...markets Euronac, an N-acetylcysteine solution for corneal healing, and Tobrabact, an ocular antibiotic. Nicox said Doliage...
Items per page:
1 - 1 of 1
BioCentury | Nov 10, 2014
Company News

Doliage, Nicox deal

...Nicox acquired French ophthalmic play Doliage for EUR5 million ($6.2 million) in newly issued Nicox shares...
...of its strategy to develop an ophthalmic commercial infrastructure in the five major European markets. Doliage...
...markets Euronac, an N-acetylcysteine solution for corneal healing, and Tobrabact, an ocular antibiotic. Nicox said Doliage...
Items per page:
1 - 1 of 1